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Available online 25 July 2009The interposed nuclei (IN) of the intermediate cerebellum are critical components of the
circuits that control associative learning of eyeblinks and other defensive reflexes in
mammals. The IN, which represent the sole output of the intermediate cerebellum, receive
massive GABAergic input from Purkinje cells of the cerebellar cortex and are thought to
contribute to the acquisition and performance of classically conditioned eyeblinks. The
specific role of deep cerebellar nuclei and the cerebellar cortex in eyeblink conditioning are
not well understood. One group of studies reported that blocking GABAA neurotransmission
in the IN altered the time profile of conditioned responses (CRs), suggesting that the main
function of the cerebellar cortex is to shape the timing of CRs. Other studies reported that
blocking GABAA neurotransmission in the IN abolished CRs, indicating a more fundamental
involvement of the cerebellar cortex in CR generation.When examining this controversy, we
hypothesized that the behavioral effect of GABAA blockers could be dose-dependent. The IN
of classically conditioned rabbits were injected with high and low doses of picrotoxin and
gabazine. Both GABAA blockers produced tonic eyelid closure. A high dose of both drugs
abolished CRs, whereas a less complete block of GABAA-mediated inputs with substantially
smaller drug doses shortened CR latencies. In addition, low doses of picrotoxin facilitated
the expression of unconditioned eyeblinks evoked by trigeminal stimulation. These results
suggest that the intermediate cerebellum regulates both associative and non-associative
components of the eyeblink reflex, and that behavioral effects of blocking Purkinje cell
action on IN neurons are related to collective changes in cerebellar signals and in the
excitability of extra-cerebellar eyeblink circuits.





The intermediate cerebellar cortex and interposed nuclei (IN)
are important parts of circuits controlling the learning and
expression of anticipatory withdrawal responses, such as
classically conditioned eyeblinks (CRs). The IN are the output
of the intermediate cerebellum, and GABAergic Purkinje cells
of the cerebellar cortex are the main source of their inner-racha).
Open access under CC BY-NC-NDvation (Ito, 1984). As a consequence of this functional
arrangement, studiesmanipulating GABAA receptor-mediated
neurotransmission in deep cerebellar nuclei offer important
insights into cerebellar control of eyeblink motoneurons. It is
known that activating GABAA receptors with muscimol
suppresses the modulation and spontaneous activity of IN
neurons (Aksenov et al., 2004), and this treatment blocks
expression of CRs (Krupa et al., 1993; Bracha et al., 1994). license.
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restricted to CRs. Cerebellar nuclear microinjections of mus-
cimol also down-regulate the amplitude of airpuff-evoked
unconditioned trigeminal eyeblinks (Bracha et al., 1994;
Jimenez-Diaz et al., 2004) and block instrumental eyelid
closure (Bracha et al., 2001). The inactivation data together
with the fact that neuronal activity in intact IN correlates with
stimuli and movements during conditioned and uncondi-
tioned blinks (Berthier and Moore, 1990; Aksenov et al., 2004;
Jimenez-Diaz et al., 2004; Zbarska et al., 2008) suggest that the
modulation of neuronal activity in the intermediate cerebel-
lum, coupled with the out-going tonic excitatory drive, control
a range of learned and reflexive eyeblink behaviors.
Additional understanding of the intermediate cerebellar role
in eyeblink control can be gained from studies that block
GABAergic neurotransmission in cerebellar output nuclei. In
contrast tomuscimol, infusing the INwith the chloride channel
blocker picrotoxin (PTX) dramatically elevates the spontaneous
firing of IN neurons and decreases modulation of their activity
during CR expression (Aksenov et al., 2004). Thus far, behavioral
effects of blocking cerebellar nuclear GABA neurotransmission
were not studied systematically and several studies of CR
performance yielded conflicting results. Bao et al. (2002) and
Garcia andMauk (1998) reported that IN injections of picrotoxin
or gabazine (GZ) invariably decreased CR latency, leading to
so called short-latency conditioned responses (SLRs). In con-
trast, others reported that IN infusions of PTX abolish CRs (Bao
et al., 2002; Mamounas et al., 1987; Attwell et al., 2002; Aksenov
et al., 2004). The cause of these variable PTX effects is not clear.
In addition to reports on the effects of cerebellar inactivations/
lesions in rabbits, studies have also been conducted on human
subjects, indicating similar involvement of the intermediate
cerebellum in the control of the onset timing and amplitudes of
eyeblink responses in humans (Gerwig et al., 2005).
Based on our previous report of a dose-dependent effect of
PTX on IN neuronal activity (Aksenov et al., 2004), we propose
that behavioral outcomes of injecting the IN with GABAAFig. 1 – Reconstruction of injection sites in the IN for GZ (stars, n=
n=4) for Experiment #2. The identified sites were transferred to a
(A–D) Four adjacent, 0.5-mm sections through the cerebellum, arr
directly on or in close proximity to the anterior interposed/dentat
nucleus; LV, lateral vestibular nucleus; SV, superior vestibular n
scp, superior cerebellar peduncle; icp, inferior cerebellar peduncreceptor antagonists are related to the extent of the block. We
hypothesized that a partial disruption of GABAergic neuro-
transmission in eyeblink-related neurons should produce
SLRs and that a complete block of inhibitory inputs will
abolish CRs. To address this hypothesis, we infused the IN of
classically conditioned rabbits with low and high doses of
GABA antagonists. In the second part of this study we
investigated the parallel effects of PTX infusions on CRs and
visual and trigeminal unconditioned responses (URs). Here we
report that a more complete block of GABAA receptor-
mediated neurotransmission with high doses of PTX and GZ
abolished CRs. In contrast, lower doses of PTX and GZ
produced SLRs, increased tonic eyelid closure, and facilitated
unconditioned trigeminal eyeblinks.2. Results
2.1. General observations
When injected in the IN at sites where previous small injec-
tions of muscimol abolished CR expression, both GZ and PTX
had a dose-dependent effect on eyeblink expression. At small
doses, both drugs shortened CR latency and increased tonic
eyelid closure. In addition, low-dose PTX increased the
amplitude of URs to a weak airpuff US and altered the velocity
and duration of URs evoked by the normal airpuff intensity. At
higher doses both drugs suppressed CRs. Besides their effect
on eyelid movements, both drugs exaggerated responses to
the airpuff US causing a more generalized withdrawal
response encompassing neck and forelimb movements that
drew the animal's head away from the air stimulation.
Notably, tonic eyelid closure and withdrawal-related postural
asymmetry disappeared immediately after the animal was
removed from the restraint box. All of these effects were
observed at injection sites located directly at or in the near
vicinity of the left anterior IN (Fig. 1).3) and PTX (circles, n=3) for Experiment #1 and PTX (triangles,
set of standardized coronal sections of the rabbit cerebellum.
anged in rostral–caudal order. All injection sites were located
e nuclear border. InA, anterior interposed nuclei; DN, dentate
ucleus; InP, posterior interposed nuclei; FN, fastigial nucleus;
le.
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(Experiment #1)
The effects of both drugs on CR expression were dose-
dependent, yielding either SLRs or CR abolition. Drug doses
that led to these effects varied between rabbits. For example, a
dose that shortened latencies of CRs in one rabbit could
abolish CRs in another. Consequently, both the low and high
doses were individually titrated for each animal. Our criterion
for the high-dose was suppression of CR incidence to 30% or
less in at least one post-injection block of 10 trials. The low-
dose was identified based on the appearance of SLRs lasting at
least 10 min (about 30 trials).
2.2.1. Low-dose effects
When compared to control aCSF injections (Fig. 2C), low-dose
GZ injections (0.13–0.51 nmol) significantly shortened CR
latencies (Figs. 2A, 3A, F1,2=29.91, p=0.032). The mean pre-
injection eyeblink latency was 155.72±15.03 ms and it
declined immediately to 96.89±15.80 ms in the first post-
injection block of trials, peaking in the fifth at 78.41±20.57 msFig. 2 – Examples of stack plots of eyeblinkmechanograms showin
injected in the IN. Each experiment begins at the top with each me
filtered by subtracting themean pre-stimulation eyelid position in
low-dose GZ. Following the injection (indicated with arrow), the la
CS andUSonsetmarkers)was shortened for the remaining60 trials
injected. Following the injection, CRswere gradually abolished. (C)
40 pre-injection trials. There was no vehicle effect on the expressi(Fig. 4C). Typically, SLRs were super-imposed on the back-
ground of GZ-induced tonic eyelid closure (Fig. 3A). Mean pre-
injection eyelid aperture was 8.42±1.28% of maximum eyelid
closure. Following GZ, rabbits had a tendency to ‘squint,’
significantly reducing their mean pre-eyeblink eyelid aperture
nearly 6-fold to 56.69±3.87% (Fig. 5A, F9,18=6.97, p=0.00025). In
parallel to changes in eyeblink latency, GZ significantly
reduced CR amplitude measured relative to eyelid aperture
before the eyeblink (Figs. 2A, 3A and 5C, F9,18=2.96, p=0.024).
However, since these small amplitude CRs were executed on
the background of a partially closed eye, the CR peak
(measured relative to maximally opened eyelids) actually
increased following the injection. Control injections of aCSF
had no effect on CR latencies, amplitudes, or on baseline
eyelid aperture (Figs. 4C, 5A, and C).
Similar to GZ, injections of low-dose PTX (0.31–4.98 nmol)
shortened eyeblink latency. However, this effect was notably
delayedwhen compared to GZ and it developed only in the last
four blocks of the 10-block post-injection period (Fig. 4D,
F13,26=3.48, p=0.0032). This difference in the effect onset was
most likely related to differences in effectiveness of drugg the effects of GZ on conditioned eyeblink performance when
chanogram representing 1 trial. All mechanograms were
the corresponding trial. (A) An experiment with an injection of
tency of conditioned responses (upward deflections between
. (B) Identical toplotAbut in this experiment, high-doseGZwas
Control for both A and B inwhich aCSF was injected following
on of CRs in this experiment.
Fig. 3 – Three dimensional surface plots of the individual examples of eyeblinkmechanograms shown in Fig. 2. In this display,
eyeblink mechanograms were not filtered to preserve information about the tonic eyelid position. Each cut through the
surface plot corresponds to one trial and the colors, together with the z axis, code the eyelid aperture (dark green = open,
yellow = intermediate, dark red = mostly closed). (A) one hundred trials illustrating the effect of low-dose GZ. The GZ injection
(thick arrow) induced a long lasting tonic eyelid closure, coupled with decreased eyeblink amplitude and SLRs. (B) Effect of
high-dose GZ showing SLRs super-imposed on a tonically closed eye. Shortly thereafter, the tonic eyelid closure subsided and
CRs were gradually abolished. (C) control experiment for both A and B where aCSF, injected after 40 pre-injection trials, had no
effect on tonic eyelid closure.
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Fig. 4 – Effects of low (circle) and high doses (squares) of GZ and PTX onmeans (±SE, n=3) for CR incidence and eyeblink latency.
(A) Effect of GZ on CR incidence. While high-dose GZ suppressed CRs, low-dose GZ and control injections of vehicle (triangles)
had minor or no effect on CR incidence. (B) Effect of PTX on CR incidence. Similar to GZ, high-dose PTX suppressed CRs,
but CRs had a greater tendency to recover toward the end of the experiment. (C) Effect of GZ on eyeblink latency. High-dose GZ
increased CR latency whereas low-dose decreased the CR onset time. (D) effect of PTX on eyeblink latency. Effects of PTX
are similar to GZ, except that low-dose PTX took 60 trials to shorten CR latency. In A–D, injections of aCSF (triangles) had no
effect on CR expression.
29B R A I N R E S E A R C H 1 2 9 2 ( 2 0 0 9 ) 2 5 – 3 7diffusion. Mean eyeblink latency decreased from 177.95±
9.53 ms pre-injection to 104.41±25.79 ms by post-injection
block 10. Also similar to GZ, PTX increased tonic eyelid closure
(Fig. 5B, F13,26=2.13, p=0.049) and it reduced CR amplitude
(Fig. 5D F13,52=4.09, p=0.00013) while increasing the absolute
eyeblink peak in the CS – US period. Low doses of GZ and PTX
had only a moderate effect on CR incidence, being slightly
reduced and tending to recover toward the end of experiments
(Figs. 4A–B).
2.2.2. High-dose effects
Effects of high doses of GZ (0.51–1.02 nmol) and PTX (0.62–
7.47 nmol) were remarkably different from low-dose injections
of these drugs. Most notably, both GZ and PTX at high doses
suppressed CRs. An individual example in Figs. 2B and 3B
shows that shortly after the injection of GZ, CRs were
abolished, contrasting with the CR latency-shortening effects
of low-dose GZ in the same animal and injection site (Figs. 2A,
3A). At the group level, high doses of GZ and PTX gradually, but
significantly suppressed CR incidence (Figs. 4A–B) when
compared to the pre-injection performance and to the control
experiment (GZ: F9,18 =9.21, p=0.00004, PTX: F13,26 =5.25,
p=0.0002). This gradual suppression of CRs was paralleled by
a gradual increase of eyeblink latency in the CS – US period(Figs. 4C–D, GZ: F9,18 = 4.29, p=0.0041, PTX: F13,26 =5.23,
p=0.00017). While the effect of high-dose GZ on tonic eyelid
closure was transient (Fig. 5A), high-dose PTX produced
sustained eyelid closure, nearly doubling from 21.25±3.40%
pre-injection to 41.42±4.78% of the full eyelid closure post-
injection (Fig. 5B, F13,26=0.64, p=0.000031).
2.3. Effects of low-dose picrotoxin on CR and UR
expression (Experiment #2)
In Experiment #1, we demonstrated how low doses of PTX
affected CR expression. In considering whether disinhibiting
the IN affects URs, four rabbits were injected with an SLR-
eliciting dose of PTX so parallel effects of this treatment on CR
and UR expression could be examined. In these animals,
paired CS + US trials were intermixed with three different
types of US trials: light, weak airpuff, and regular airpuff. As
expected, injections of low-dose PTX (2.49 to 6.22 nmol)
shortened CR latencies (Fig. 6A). The repeated-measures
ANOVA revealed a significant drug and block-of-trials inter-
action (Fig. 7A, F3,9=8.061, p=0.0064). Low-dose PTX shortened
baseline CR latency from 197.20±20.85 ms pre-injection to
99.43±13.53 ms in the third block of post-injection trials. The
tonic eyelid closure increased from 5.36±0.76% pre-injection
Fig. 5 – Effects of low (circle) and high doses (square) of GZ and PTX on the means (±SE, n=3) for eyeblink baseline, peak,
and amplitude. (A) Effect of GZ on eyeblink baseline expressed in percentage of maximum eyelid closure. Low-dose GZ
produced an immediate and long lasting eyelid closure. The eyelid closure resulting fromhigh-dose GZwas short-lasting and it
recovered within 20 trials. (B) Effect of PTX on eyeblink baseline. Both low and high-dose PTX induced long lasting eyelid
closure. Control injections of aCSF (triangles) in A and B did not affect eyeblink baseline. (C) Effect of a low, SLR-inducing dose
of GZ on eyeblink peak (diamonds) and amplitude (circles). Injected (inj.) after 40 pre-injection trials, GZ immediately
increased eyeblink peak and decreased amplitude. (D) Effect of SLR-inducing, low-dose PTX on eyeblink peak and amplitude.
Similar to GZ, PTX increased CR peaks but decreased eyeblink amplitudes.
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27.53±8.26% in the third (F3,9=4.23, p=0.04). In parallel with
tonic eyelid closure, the CR peak increased from 32.70±7.41%
in pre-injection trials to 59.05±12.04% in the third post-
injection block (Fig. 8B). This CR peak finding was revealed
as main effects for the within-subject factor, blocks (F3,9=4.70,
p=0.031), and for the between-subject factor, PTX vs aCSF
(F3,9=11.81, p=0.041). Injections of vehicle had no effect on CR
latency or tonic eyelid position. Since CR amplitudes were not
significantly affected by PTX (Fig. 8A), it is likely that changes
in the CR peak amplitude were due to increased tonic eyelid
closure.
2.3.1. URs to the weak airpuff
Among the three types of URs tested, eyeblinks to the weak
airpuffwere themost affected.Most notably, PTX increasedUR
amplitude during the same time period in which the drug
affected CR expression (Figs. 6A–B). The mean amplitude of
URs to the weak airpuff increased from 9.01±2.65% pre-
injection to 45.88±4.48% during the third block of post-
injection trials (Fig. 8C, F3,9=10.75, p=0.00025). Mean URpeaks to the weak airpuff likewise increased from 13.66±
2.42% during the pre-injection block of 10 trials to 67.64±8.45%
during the third block of post-injection trials (Fig. 8D,
F3,9=11.18, p=0.0022). Similar to the PTX effect on CR latencies,
mean UR latencies to the weak airpuff were shortened 50%
post-injection (Fig. 7B, F3,9=5.095, p=0.025), steadily decreasing
from 68.43±9.80ms pre-injection to 33.80±1.91ms in the third
block of post-injection trials. Control injections of vehicle had
no effect on latency or amplitude of URs to the weak airpuff
(Figs. 7B, 8C).
2.3.2. URs to the strong airpuff and to the light
PTX did not significantly affect UR amplitude to the strong
airpuff (Fig. 8E, 49.58±11.83% in the pre-injection and 61.87±
5.55% in the third block of post-injection trials). Even though
the size of eyeblinks did not changemuch, the resulting eyelid
closure significantly increased due to the presence of the tonic
squinting before blinks (Fig. 9A). The mean peak of URs to the
strong airpuff (the response peak represents a sum of the pre-
eyeblink tonic eyelid position and the eyeblink amplitude),
increased from 54.33±11.74% pre-injection to 91.34±3.84%
Fig. 6 – Example of effects of PTX injections in the IN on the performance of conditioned eyeblinks and on unconditioned
responses evoked by weak airpuffs. Both stack plots of eyeblink mechanograms are a complete printout from the same
experiment. The experiment begins at the top,with each trace representing one trial, and the time of injection is indicated by an
arrow. (A) In paired CS + US trials, PTX shortened the latency of CRs (positive trace deflections between the CS and USmarkers).
(B) In weak airpuff-alone trials, PTX increased UR amplitude approximately at the same time when SLRs were observed in A.
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p=0.019). The maximum instantaneous velocity of eyelid
closure during eyeblinks to the strong airpuff nearly doubled
from 0.99±0.26% per ms pre-injection to 1.93±0.23% per ms
during the third block of post-injection trials (Fig. 9C,
F3,9=4.49, p=0.035). Besides its effect on eyelid closure velocity,
PTX also delayed eye re-opening which was manifested as
greater eyelid closure still present at the end of the 1400-ms
recording period. Delayed eye re-opening was apparent in
eyeblink averages (Fig. 9A). At the end of the 1400ms recording
period, eyelid closure had increased from 9.44±1.30% in pre-
injection to 53.28±12.76% during the third block of post-
injection trials (Fig. 9A, F3,9=9.65, p=0.00036). Injections of
vehicle had no effect on the peak, profile, or velocity of URs to
the strong airpuff (Figs. 8E–F, 9B).
PTXdidnothavea significant effect onURs to the light.At the
group level, the amplitudeofURs to the lightwas 22.86±8.54% in
the pre-injection period, 29.13±9.91% (F1,9=0.28, p=0.63) during
the second and 20.69±5.96% (F1,9=0.090, p=0.78) during the
third block of post-injection trials. The latency of URs to the
light tended to decrease from 132.27±15.85 ms pre-injection to
114.69±11.38 ms (F1,9=3.77, p=0.15) during the third block of
post-injection trials.3. Discussion
The present study demonstrated that blocking GABAA neuro-
transmission in the IN with PTX or GZ affects CRs in a dose-
dependent manner. While high doses of GABAA blockers
suppressed CR expression, lower drug doses shortened CR
latency. Besides their effects on CRs, the SLR-inducing doses of
PTX also affected non-associative components of eyelid
movements; they increased tonic eyelid closure and facilitated
URs evoked by trigeminal stimulation.
3.1. Effects on CR expression
We hypothesized that prior variance in results of blocking
GABAA receptor-mediated neurotransmission in the IN on CR
expression could be related to the extent of the GABAA block.
Our data presented here confirm this notion. High amounts of
PTX and GZ suppressed CRs. This finding confirmed previous
reports of CR abolition (Mamounas et al., 1987; Attwell et al.,
2002; Aksenov et al., 2004). On the other hand, lower amounts
of both drugs, when administered at sites where high doses
abolished CRs, had a minor effect on CR incidence, but
Fig. 7 – Effects of PTX (squares) injections (inj.) on the means
(±SE, n=4) for CR and UR latencies. (A) Effect of PTX on
eyeblink latency in paired CS + US trials. PTX reduced CR
latency. (B) Effect of PTX injections to the IN on UR latency
during weak airpuff trials. The UR latency gradually
decreased when compared to the pre-injection level. (C) PTX
had no effect on UR latency during regular intensity airpuff
trials. Injections of aCSF (triangles) had no effect on eyeblink
latency during either type of trial.
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reports of SLRs induced by cerebellar nuclear injections of
similar amounts of PTX (0.2–0.4 nmol in Garcia and Mauk,
1998; 2 nmol inMedina et al., 2001) or GZ (0.04 nmol in Ohyama
et al., 2006). Although all injection sites in this study were
located in the IN region (Fig. 1), and their proximity to
eyeblink-related parts of cerebellar nuclei was functionally
confirmed with muscimol injections abolishing CRs, effective
doses of GABAA blockers had to be titrated to optimize effects.
In general, smaller amounts of drugs were required for SLRs
and CR abolition at sites with the best muscimol effects,
suggesting a dependency on the amount of drug diffusing
around the eyeblink representation in deep cerebellar nuclei.
Differences between the effects of high and low drug doses
could result from drug spreading to the overlying cerebellarcortex. Blocking GABAA neurotransmission in the cerebellar
cortex increases the tonic firing rate of GABAergic Purkinje
cells (Thomsen et al., 2004). Assuming the high drug dose did
diffuse into the non-targeted cerebellar cortex, increased
Purkinje cell activity would inhibit the IN and abolish CRs.
However, this effect would be prevented by the simultaneous
suppression of GABAA neurotransmission in the targeted deep
cerebellar nuclei. Thus, conjectured drug diffusion to the
cerebellar cortex does not explain CR abolition by high doses
of GABAA blockers.
In agreement with previous reports (Medina et al., 2001),
SLR-inducing doses of both blockers reduced CR latency and
changed the temporal profile of CRs, which frequently
peaked before the US onset (Figs. 2A, 3A). GZ reduced CR
amplitude (Figs. 2 and 5) when measured relative to the
eyelid position before application of the CS. Effects of PTX on
CR amplitude were less pronounced, ranging from a small
decrease in Experiment #1 (Fig. 5) to no change in Experiment
#2 (Fig. 8). On the other hand, CR peaks measured relative to
the maximally open eye, increased following both drugs and
in both experiments (Figs. 5, 8). These seemingly contra-
dictory effects were due to a drug-induced tonic eyelid
closure. Following drug injections, CRs were evoked on a
background of tonic eyelid closure and the same or smaller
blinks resulted in absolute eyelid closure larger than base-
line blinks recorded before injections or those recorded after
control.
3.2. Effects on non-associative components of blinking
High and low doses of PTX and low-dose GZ elicited sustained
tonic eyelid closure during which animals maintained par-
tially closed eyelids both during and between trials. This
finding confirms and extends our previous reports of PTX
effects on tonic eyelid position in instrumental and classical
conditioning tasks in the rabbit (Bracha et al., 2001; Aksenov
et al., 2004). In our study of instrumental eyelid behavior we
found that inactivating the IN with the GABAA agonist,
muscimol, disrupts instrumentally conditioned tonic eyelid
closure (Bracha et al., 2001). Since down-regulating the
neuronal firing rate in the IN with muscimol produces tonic
eyelid opening, whereas increasing the IN neuronal activity
with GABAA antagonists increases tonic eyelid closure, it
appears that tonic IN activity controls tonic eyelid aperture. In
this regard, it was surprising that high doses of GZ produced
only transient tonic eyelid closure, followed by eyelid opening
at later stages of the experiment. Pertinent to this finding, in
earlier work we observed that injecting the IN with the GABAA
antagonist bicuculline at low concentrations increased the
tonic activity of IN neurons and at high concentrations evoked
bursting followed by long periods of inactivity (Bayev and
Bracha, unpublished observations). If GZ has similar proper-
ties, then low doses would increase the tonic activity of IN
neurons (Chen and Evinger, 2006) and enhance tonic eyelid
closure. On the other hand, high doses would reduce the IN
spontaneous firing rate, leading to eyelid opening and CR
abolition. However, based on previously reported data, the
different effects on tonic eye closure of PTX compared to GZ
can be explained by the distinct mechanisms by which they
affect GABAA channels (Bouairi et al., 2006).
Fig. 8 – Effects of PTX (squares) on the means (±SE, n=4) of amplitudes (left column) and peaks (right column) of CRs and
airpuff-evoked URs. (A) PTX injections (inj.) did not significantly affect CR amplitude in CS + US trials. (B) PTX injections
increased the CR peak in CS + US trials. (C) The amplitude of responses to the weak airpuff US increased following PTX
injections. (D) The peak of responses to theweak airpuff US also increased following PTX injections. (E) The amplitude of regular
airpuff-evoked URs was not affected by PTX. (F) The peak of regular airpuff URs slightly increased following PTX. Neither
peaks nor amplitudes of responses in all three conditions were affected by control injections of aCSF (A–F).
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URs, rabbits were presented with trigeminal and visual
stimuli. Analyses of latencies, amplitudes, and velocity
profiles showed no effect on photic URs. In contrast, PTX
facilitated URs evoked by airpuffs. This was most pronounced
in weak airpuff trials, where PTX shortened UR latencies and
increased UR amplitudes. In strong airpuff trials, PTX
increased the maximum instantaneous velocity of eyelid
closure and delayed eyelid re-opening following the blink.
These findings corroborate observations of GZ effects on URs
in anesthetized rats (Chen and Evinger, 2006) and complement
reports of opposite effects of IN lesions and inactivations in
the rabbit (Welsh and Harvey, 1989; Welsh, 1992; Bracha et al.,
1994). Here we have shown that SLR-inducing levels of GABAA
neurotransmission affect non-associative eyelid movements.These data collectively demonstrate IN involvement in the
control of tonic eyelid closure and trigeminal stimulation-
evoked URs.
3.3. Implications for cerebellar control of eyeblinks
The present findings illuminate the controversy about PTX's
effect on CR expression (Garcia and Mauk, 1998; Attwell et al.,
2002). We have shown that blocking GABAA neurotransmis-
sion affects CRs in a dose-dependent manner. Blocking either
GABAA receptors or chloride channels with low drug doses
induces SLRs. On the other hand, administering higher drug
doses at the same injection sites abolishes CRs. In their
original reports, Mauk and colleagues suggested that SLRs are
evoked when GABAergic Purkinje cells are functionally
Fig. 9 – Effects of PTX on the time profile and instantaneous
velocity of URs evoked by strong airpuff. (A) average
eyeblinks (n=4) to the strong airpuff in one block of trials
before (Pre-inj.) and three blocks of trials following (Post 1–3)
PTX injections. PTX increased tonic eyelid closure seen as
increased signal levels before the US onset. Also, eyelid
re-opening was delayed in post-injection trials as indicated
by the higher signal at the end of the recording period.
(B) average eyeblinks to the strong airpuff before and after
control injections of aCSF. Injections of vehicle had no effect
on the shape of strong airpuff-evoked eyeblinks. (C) peak
velocity of URs to the strong airpuff (mean±SE, n=4), which
was calculated in a sliding window of 20 ms as the first
derivative of rise-to-peak velocities of individual trials of URs
to the strong airpuff, and then it was averaged by blocks. PTX
significantly increased the maximum instantaneous velocity
of strong airpuff URs.
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cerebellar nuclei (Garcia and Mauk, 1998; Medina et al., 2001).
Our results do not support this notion.We propose that during
SLRs, cerebellar cortical projections are not disconnectedcompletely because increasing the drug dose further aggra-
vates behavioral effects, resulting in CR abolition.
An important contribution of the present study is showing
that SLR-inducing injections of PTX affect non-associative
components of blinking. This confirms previous suggestions
that the intermediate cerebellum controls both classically
conditioned and unconditioned eyeblink reflexes (Welsh and
Harvey, 1989; Bloedel and Bracha, 1995; Delgado-Garcia and
Gruart, 2006; Chen and Evinger, 2006). It is known that neurons
in the interposed nuclei respond to both the tone CS and
trigeminal US (Berthier and Moore, 1990; Aksenov et al., 2004;
Jimenez-Diaz et al., 2004; Chen and Evinger, 2006). Conse-
quently, it is possible that effects of PTX and GZ could be
related to changes of IN task-related signals. However, the
effects of IN pharmacological manipulations are also very
likely related to changes in tonic IN activity. It is paramount to
note that PTX and GZ dramatically enhance the spontaneous
firing rate of IN neurons (Aksenov et al., 2004; Chen and
Evinger, 2006). These IN neurons then send excitatory projec-
tions to the red nucleus and other mesencephalic eyeblink-
related targets. In addition, neurons in the red nucleus receive
CS and US information (Desmond and Moore, 1991) and
project to sensory trigeminal (Davis and Dostrovsky, 1986;
Godefroy et al., 1998) and facial nuclei (Holstege and Tan,
1988). Thus, it is possible that the elevated spontaneous IN
activity increases excitability of extra-cerebellar eyeblink pre-
motoneurons and this could affect CR and UR performance in
a manner unrelated to learning. Since PTX and GZ affect both
neuronalmodulation and spontaneous activity simultaneous-
ly, dissociating contributions of these two processes to CR and
UR performance is difficult and the present study cannot
resolve this question ; for review, see Bracha et al. (2009).
The most plausible explanation of the effects of low doses
of PTX andGZ is that they partially block the inhibitory drive of
Purkinje cells and IN GABAergic interneurons. This enhances
the spontaneous firing rate of IN neurons, and reduces their
depth of modulation (Aksenov et al., 2004; Chen and Evinger,
2006). The elevated IN firing in turn increases the activity of
eyeblink pre-motoneurons and motoneurons, and modulates
transmission of sensory information in the sensory trigeminal
system. The high spontaneous firing within eyeblink circuits
enhances tonic eyelid closure. Importantly, this tonic effect on
eyelid position is context-dependent, because removing the
animal from the restraining box restores normal eyelid
aperture. This suggests a so far unknown and context-depen-
dent gating mechanism that can over-ride the effect of the
drug-induced high IN firing rate on pre-motoneurons. The
reduced modulation of IN neurons is transmitted to mesen-
cephalic pre-motoneurons, which themselves are now more
excitable and respondmore vigorously to IN signals as well as
to direct CS and US inputs. The collective changes both inside
and outside of the cerebellum are then responsible for
facilitating responses to the CS and trigeminal US. It is not
clear whether this mechanism of eyeblink facilitation extends
to circuits controlling optic URs. Even though post-PTX
amplitudes of optic URs tended to increase and their latencies
slightly decreased, these changes were not significant. This
seems to indicate that optic URs are not regulated by the
cerebellum to the same extent as trigeminal eyeblinks. We
cannot exclude, however, that the tonic eyelid closure fol-
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light stimulus during some trials. This process could have
obscured detecting facilitation of optic URs. Further clarifica-
tion of this issue will require visual stimulus delivery that is
independent of the tonic eyelid position. In our previous study
we have shown that large doses of PTX dramatically increase
IN firing rates and suppress neuronal responses to the CS and
US (Aksenov et al., 2004). It is likely that this over-excitation of
IN neurons, together with the associated high excitability in
their efferent targets, saturate the circuit's capacity to respond
to the CS and this suppresses CRs on the background of
pronounced eyelid closure. As addressed above, the mecha-
nism of high GZ doses is different – it appears to suppress IN
activity. The resulting suppression of cerebellar task-related
signals and the decreased excitatory drive to eyeblink pre-
motoneurons counter-balance tonic eyelid closure and sup-
presses CRs.4. Experimental procedures
4.1. Subjects
The experiments were performed on 10 male New Zealand
White Rabbits (Harlan; Indianapolis, IN) weighing 2.5–3.0 kg
(3–4 months old at time of surgery). Rabbits were housed
individually on a 12-hour light/dark cycle and provided food
and water ad libitum. All experiments were performed in
accordance with the National Institutes of Health's “Principles
of Laboratory Animal Care” (publication No. 86-23, revised
1985), the American Physiological Society's “Guiding Principles
in the Care and Use of Animals,” and the protocol approved by
Iowa State University's Committee on Animal Care.
4.2. Surgery
Using aseptic techniques, surgery was performed on naive
rabbits anesthetized with a mixture of ketamine (50 mg/kg),
xylazine (6 mg/kg) and acepromazine (1.5 mg/kg). The head
was secured in a stereotaxic apparatus with lambda posi-
tioned 1.5 mm ventral to bregma. A stainless steel injection
guide tube (28-gauge thin-wall tubing) was stereotaxically
implanted 0.5 mm dorsal to the expected location of the left
anterior IN ((0.69x+4.8)−x mm rostral from lambda, x being
the horizontal distance between bregma and lambda in mm:
5.3 mm lateral and 13.5 mm ventral to lambda). A 33-gauge
stainless steel stylet was inserted into the guide tube in-
between experiments to protect its patency. The guide tube,
anchor screws, and a small Delrin block designed to accom-
modate an airpuff delivery nozzle and eyeblink sensor were
secured in place with dental acrylic. All animals were treated
with antibiotics for 5 days during recovery from surgery.
4.3. Training procedures
Following recovery from surgery, rabbits were adapted to a
restraint box in three daily 30-minute sessions. Adapted
rabbits were trained in the standard classical conditioning
paradigm until they reached at least 90% CRs for 3 consecutive
days. The conditioned stimulus (CS) was an 85-dB, 450-ms,1-kHz tone, super-imposed on a continuous 70-dB white noise
background. The CS co-terminated with a 100ms, 40 psi at the
source airpuff unconditioned stimulus (US) directed to the left
eye. The inter-stimulus interval was 350 ms and each training
session consisted of 100 trials presented in pseudorandom,
15–25 s inter-trial intervals. All experiments were conducted
in a sound-attenuated chamber.
Animals tested in the UR performance experiments
(Experiment #2) were adapted to a mixed paradigm following
training. The paired presentation of the CS + US was alter-
nated with three different types of US in Experiment #2: a
normal airpuff US, a weak airpuff US (100 ms, 4–5 psi at the
source), and a photic US (30 ms flash of four white LEDs
positioned in front of the left eye; light intensity was dimmed
to only elicit near-threshold URs). This mixed-stimulation
paradigm consisted of repeated blocks of 10 trials: 4 paired CS
+ US, 2 normal US, 2 weak airpuff US, and 2 light US trials were
pseudorandomly intermixed.
4.4. Injection procedures
Injections were delivered via a 33-gauge stainless steel
injection needle which was connected via transparent Tygon
tubing to a 10-μL Hamilton syringe. The injection tubing was
first filled with nanopure water, and then a small bubble was
drawn into the end of the injection needle before drawing in
drug. The bubble was used for monitoring the injected volume
relative to gradationmarks on the tubing. The injection needle
was inserted in the guide tube prior to beginning the
experiment. A pre-injection period of 40 trials (or 50 trials in
Experiment #2) was presented to rule out needle insertion
effects and to assess baseline eyeblink performance. Follo-
wing the pre-injection period, drug microinjections were
manually administered at a rate of 0.5 μL/min. To assess the
drug effect, training continued for 60–150 additional trials.
The present study had two objectives. In the first group of
rabbits (n=6), CRperformancewasexamined following injection
of two GABA antagonists, picrotoxin (PTX, chloride channel
blocker; Sigma-Aldrich, USA) and gabazine (GZ, GABAA receptor
antagonist; Ascent Scientific, Weston-super-Mare, UK). Of the 6
animals, 3wereused in thePTX groupand 3wereused in theGZ
group. In preliminary experimentswe found that effects of both
drugs were dose-dependent besides being animal and injection
site-dependent. For this reason, effective injection sites and
drug doses in each animal were determined. The starting doses
for PTX and GZ were 0.62 nmol and 0.51 nmol, respectively. If
CRs were abolished after the injection, this drug concentration
was considered the ‘high-dose,’ and the drug dose was
progressively decreased on consecutive days until SLRs were
observed (the ‘low-dose’ for the drug) or until no drug effect was
detected. If no effect on CR performance was found following
the initial drug injection, the drug dose was progressively
increased until SLRs (the ‘low-dose’) andCR abolition (the ‘high-
dose’) were detected. Only one drug was injected on any given
experimentation day. Both GZ and PTX were dissolved in
artificial cerebrospinal fluid (aCSF) and their pH was adjusted
to 7.4± 0.1. All injections of PTX and GZ were performed at CR
expression-related deep cerebellar nuclear sites where 0.5 μL of
muscimol (1.75 nmol) completely suppressed conditioned eye-
blinks (Bracha et al., 1994).
36 B R A I N R E S E A R C H 1 2 9 2 ( 2 0 0 9 ) 2 5 – 3 7In the second group of animals (n=4), the parallel effects of
PTX on CR and UR expression were examined (Experiment #2).
In this group of rabbits, PTX was injected in 0.5-μL (0.3 nmol)
increments beginning immediately following 50 pre-injection
trials. These injections were administered every 20 trials until
SLRs were observed or until 2.5 μL of PTX had been
cumulatively administered. In control experiments for both
Experiment #1 and Experiment #2, an equal volume of drug
vehicle (aCSF) was injected using the same injection protocol.
4.5. Data recording and analysis
Rabbit behaviorwasmonitored using an infrared video system
installed in the experiment chamber. Eyelid movements were
recorded by a frequency-modulated infrared sensor that
measures infrared light reflected from the eye and peri-orbital
region (Ryan et al., 2006). The sensor, attached to an aluminum
stage, was secured to the Delrin block on the rabbit's head
before every experiment. The output of the sensor was
amplified, digitized (25 kHz, 12-bit A/D converter), and stored
in a PC-based data acquisition system. During each trial,
1400 ms of the signal was recorded, beginning with 250 ms of
baseline before the CS onset and extending for 800 ms beyond
the US onset.
Eyeblink responses from each trial were examined off-line
for the presence of CRs within the time window between CS
and US onsets and for the presence of URs in US-alone trials.
The threshold for eyeblink detection was set to 5 standard
deviations of the baseline signal noise, which in the present
setup corresponded to an approximately 0.15 mm decrease in
eyelid aperture. The following response parameters were
measured in each trial: baseline eyelid aperture, response
latency, response amplitude and response peak. Response
amplitude was defined as the difference between the baseline
eyelid aperture and the maximum eyelid closure in the
corresponding response time window for each trial. In normal
conditions, the response amplitude reflects the degree of
eyelid closure during the blink. However, in present experi-
ments drugs infused in the IN induced squinting and blinks
occurred on the background of partially closed eyelids. To
assess the extent of eyelid closure in these conditions, we
measured the response peak, which was derived not from the
eyelid position before the blink, but rather from the eyelid
position in an animal with completely open eyelids. To
determine the signal corresponding to completely open eye-
lids, the software searched for the lowest signal value in each
experiment, and this value was assigned to the completely
open eyelid position. Thus, the response peak was calculated
as the difference between the maximum eyelid aperture
(openness) in the given session and the maximum eyelid
closure in the corresponding response time window in each
trial. All amplitudes were first measured in A/D units of the
recording system. Typical eyeblinks in rabbits consist of eyelid
closure and subsequent folding of external eyelids. Both of
these response components were detected by our IR sensor
(Ryan et al., 2006). The native amplitude measurements were
normalized by converting them to a percentage of maximum
eyeblink, assuming that the difference betweenminimumand
maximum sensor signals in a particular daily session captures
the eye both maximally open and closed. Means of eyeblinkmeasures were calculated for consecutive blocks of 10 trials in
Experiment #1. In Experiment #2, means of eyeblinkmeasures
were calculated for blocks of trials as follows: 20 paired CS +
US, 10 light, 10 weak airpuff, and 10 strong airpuff trials, which
were all randomly presented during blocks of 50 trials. In
addition, instantaneous velocities were calculated in a sliding
window of 20 ms as the first derivative of rise-to-peak
velocities of URs to light and to the strong airpuff in Expe-
riment #2. To compare time profiles of URs to the light and
strong airpuff, response averages were normalized by expres-
sing them as a percentage of their amplitude. We tested
unique hypotheses about dose dependence by conducting
separate repeated-measures ANOVAs for PTX and GZ at each
dose (high concentration: abolition-inducing, and low con-
centration: SLR-inducing). Response variables, divided into
blocks of 20 trials as the within-subject repeated measures,
weremodeled against a two-factor treatment (drug vs vehicle)
together with subject as a blocking factor. Reported F-ratios
and their p-values refer to main effects only when there
was no significant interaction between treatment and blocks-
of-trials. All group data were reported as mean±standard
error of mean, and significance was declared by an alpha
level=0.05. All statistical analyses were performed using Stat-
soft Statistica software.
4.6. Histology
Upon the conclusion of experimentation, rabbits were deeply
anesthetized with a cocktail of ketamine (100 mg/kg), xylazine
(12 mg/kg), and acepromazine (3 mg/kg). Injection sites were
marked by injecting 1 μL of tissue-marking dye. Animals were
perfused transcardially with 1 L of a phosphate-buffered
saline followed by 1 L of a tissue fixative (10% buffered
formalin). Carefully excised brains were stored in a solution of
30% sucrose and 10% formalin and subsequently sectioned
coronally at 50 μmon a freezingmicrotome. The sections were
mounted onto gelatin-coated slides, and once dry, stained
with luxol blue and neutral red. Using bright light microscopy,
injection locations were determined and plotted on standard
sections of the rabbit cerebellum.R E F E R E N C E S
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